Insider Buying: PureTech Health (LON:PRTC) Insider Purchases 36,500 Shares

PureTech Health plc (LON:PRTC) insider Robert Lyne bought 36,500 shares of PureTech Health stock in a transaction on Tuesday, July 7th. The shares were purchased at an average price of GBX 119 per share, for a total transaction of £43,435.

PureTech Health Stock Up 1.6%

Shares of LON:PRTC opened at GBX 120 on Thursday. The firm has a market capitalization of £292.10 million, a P/E ratio of -2.61 and a beta of 0.79. The company has a debt-to-equity ratio of 6.33, a quick ratio of 2.51 and a current ratio of 6.59. The stock has a 50 day moving average price of GBX 129.88 and a 200-day moving average price of GBX 127.13. PureTech Health plc has a 52-week low of GBX 104.71 and a 52-week high of GBX 148.

About PureTech Health

PureTech Health plc, a clinical-stage biopharma company, focuses on developing medicines for diseases caused by dysfunctions in the nervous, gastrointestinal, and immune systems. The company is developing a microbiome immune system drug-discovery platform and drug candidates for immune-mediated diseases; and products to induce weight loss and enhance glycaemic control through an orally administered capsule. It is also developing technology and products for screening, diagnosis, and treatment of neurological disorders, such as ADHD, autism, and depression through computer software; noninvasive neurostimulation treatment for psychiatric disorders; and combination therapy for schizophrenia.